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Streptococcus suis 2 is an important swine pathogen and an emergent zoonotic
pathogen. Excessive inflammation caused by S. suis is responsible for the high levels of
early mortality observed in septic shock-like syndrome cases. However, the mechanisms
through which S. suis 2 (SS2) causes excessive inflammation remain unclear. Thus,
this study aimed to identify novel pro-inflammatory mediators that play important roles
in the development of therapies against SS2 infection. In this study, the novel pro-
inflammatory protein HP0459, which was encoded by the SSUSC84_0459 gene, was
discovered. The stimulation of RAW 264.7 macrophages with recombinant HP0459
protein induced the expression of pro-inflammatory cytokines (IL-1β, MCP-1 and TNF-
α). Compared with the wild-type (WT) strain, the isogenic knockout of HP0459 in SS2 led
to reduced production of pro-inflammatory cytokines in RAW264.7 macrophages and in
vivo. The pro-inflammatory activity of HP0459 was significantly reduced by an antibody
against Toll-like receptor 2 (TLR2) in RAW264.7 macrophages and was lower in TLR2-
deficient (TLR2−/−) macrophages than in WT macrophages. Furthermore, specific
inhibitors of the extracellular signal-regulated kinase 1/2 (ERK1/2) pathways significantly
decreased the HP0459-induced pro-inflammatory cytokine production, and a western
blot assay showed that HP0459 stimulation induced the activation of the ERK1/2
pathway. Taken together, our data indicate that HP0459 is a novel pro-inflammatory
mediator of SS2 and induces TLR2-dependent pro-inflammatory activity in RAW264.7
macrophages through the ERK1/2 pathway.
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Introduction
Streptococcus suis is a major pathogen responsible for impor-
tant economic losses to the swine industry worldwide, particu-
larly during the past 20 years (Gottschalk et al., 2010). It causes
meningitis, septicemia, pneumonia, endocarditis, arthritis, and
other diseases in swine (Wei et al., 2009). Among the 33 serotypes
based on capsular antigens that have been described, serotype
2 is the most frequently isolated from diseased pigs, particu-
larly in Europe and Asia (Wisselink et al., 2000). Since the ﬁrst
human case was reported in Denmark in Perch et al. (1968),
more S. suis infections in humans have been documented in
several European and Asian countries as well as in North and
South America, Australia, and New Zealand (Wertheim et al.,
2009; Gottschalk et al., 2010). For a long time, it has been con-
sidered to be a fact that S. suis only infects people working with
pigs or pork-derived products (Arends and Zanen, 1988); how-
ever, S. suis infections in the general population were recently
reported in Southeast and East Asia (Gottschalk et al., 2010).
Although most reports concern sporadic cases of infection, a
large series of 151 S. suis meningitis cases was recently reported
in southern Vietnam (Mai et al., 2008). Furthermore, an impor-
tant outbreak, which involved 215 cases and 38 deaths, occurred
in China in during 2005 (Yu et al., 2006). In addition, S. suis
is considered one of the most important causes of meningitis
in humans in various locations, including Vietnam, Thailand,
and Hong Kong (Suankratay et al., 2004; Hui et al., 2005; Ip et al.,
2007; Mai et al., 2008). These ﬁndings emphasize the importance
of S. suis as an emerging zoonosis and indicate that S. suis repre-
sents a signiﬁcant public health concern (Fittipaldi et al., 2012).
The increased severity of S. suis infection in humans under-
scores the critical need to better understand the factors associated
with the pathogenesis of S. suis infection (Gottschalk and Segura,
2000).
Although several virulence-related molecules have been pro-
posed, only the capsular polysaccharide (CPS) has been proven
to play a critical role in the virulence of S. suis (Charland et al.,
1998; Smith et al., 1999; Segura et al., 2004). Some putative
virulence factors have also been reported in S. suis, such as
suilysin, muramidase-released protein (MRP), subtilisin-like
protease (SspA), and LTA D-alanylation (DltA; Smith et al.,
1992; Lun et al., 2003; Fittipaldi et al., 2008; Bonifait et al., 2011);
however, the current knowledge on the pathogenesis of S.
suis infection remains limited (Baums and Valentin-Weigand,
2009). To cause disease, S. suis must breach epithelial barri-
ers, reach and survive in the bloodstream, invade diﬀerent
organs and cause exaggerated inﬂammation (Fittipaldi et al.,
2012). The upregulated expression of several pro-inﬂammatory
cytokines and chemokines, such as tumor necrosis factor-
α (TNF-α), interleukin-1β (IL-1β), IL-6 and monocyte
chemotactic protein-1 (MCP-1), has been reported in S.
suis infection (Gottschalk and Segura, 2000; Segura et al., 2002;
Al-Numani et al., 2003). Furthermore, inﬂammation is thought
to be responsible for most clinical signs of meningitis, septicemia
and sudden death (Segura et al., 2006). S. suis sequence type
(ST) 7 was recognized as the causative agent for the Sichuan
outbreak, and streptococcal toxic shock-like syndrome (STSLS)
was observed for the ﬁrst time in this large outbreak (Ye et al.,
2006). A previous study showed that the increased virulence of
S. suis ST7 is associated with an increased ability to stimulate
excessive pro-inﬂammatory cytokines that may be responsible for
the shock syndrome (Zheng et al., 2008). In addition, the most
important clinical feature associated with S. suis is meningitis in
pigs (Gottschalk and Segura, 2000); however, the mechanisms of
S. suis crossing the blood–brain barrier (BBB) to cause meningitis
are poorly understood. Even so, some mechanisms, such as the
up-regulation of pro-inﬂammatory cytokines and increased
leukocyte traﬃcking, have been proposed to contribute to the
breakdown of the BBB (Vadeboncoeur et al., 2003; Adam et al.,
2004; Jobin et al., 2005; Tenenbaum et al., 2005). The activation
of the innate immune response depends on the recognition
of pathogen-associated molecular patterns (PAMPs). Toll-like
receptors (TLRs) are critical sensors that activate the innate
immune response (Beutler, 2009; Kawai and Akira, 2010). For
example, TLR2 can form heterodimers with TLR1 or TLR6
to recognize bacterial lipoprotein, lipoteichoic acid (LTA),
peptidoglycans (PGNs) and zymosan and induce the release
of many cytokines and chemokines responsible for inﬂamma-
tion (Akira and Hemmi, 2003; Beutler, 2004; Lachance et al.,
2013). Many previous studies have reported that TLR2 is the
major (but not exclusive) immune receptor involved in S. suis
recognition (Graveline et al., 2007; Li et al., 2010; Lecours et al.,
2012).
As mentioned above, inﬂammation has been thought to be a
hallmark of S. suis infection (Gottschalk et al., 2007). However,
the research on inﬂammation induced by S. suis remains limited.
Therefore, it is important to identify novel pro-inﬂammatory
mediators of S. suis in order to improve our understanding of
the mechanism of inﬂammation induced by this pathogen. In
our previous study, more than 50 extracellular proteins of S. suis
were expressed, including membrane proteins, secreted proteins
and cell wall proteins. And several pro-inﬂammatory proteins
were identiﬁed, of which a novel protein HP0459 displayed rather
robust pro-inﬂammatory activity (data not shown). In this study,
through measuring the IL-1β and MCP-1 levels by relative quan-
titative polymerase chain reaction (qPCR) and enzyme-linked
immunosorbent assay (ELISA), the pro-inﬂammatory ability of
HP0459 was examined. We investigated the recognition receptor
and signal transduction pathway through which HP0459 induces
IL-1β, TNF-α andMCP-1 in RAW264.7 macrophages. As a result,
we elucidated the mechanism through whichHP0459 stimulation
induces pro-inﬂammatory cytokine production.
Materials and Methods
Bacterial Strains, Plasmids and Growth
Conditions
Streptococcus suis serotype 2 strain SC-19, which was isolated
from the brain of a dead pig during the epidemic outbreak
in Sichuan province of China in 2005, was selected as the
wild-type (WT) strain. SC-19 was grown in Tryptic Soy Broth
(TSB) or on Tryptic Soy Agar (TSA) plates (Difco, MI, USA)
with 5% newborn bovine serum (Sijiqing Biological Engineering
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Materials Co., Ltd., Hangzhou, China) at 37◦C (Li et al., 2013).
A temperature-sensitive S. suis–Escherichia coli shuttle vector
(pSET4s) was used to construct the hp0459mutant, which car-
ries a spectinomycin resistance gene (spcr). pSET2, a S. suis–E.
coli shuttle vector carrying spcr , was used in the construction of
the complementary bacterium (Takamatsu et al., 2001).
Cell Culture
RAW 264.7 macrophages were grown in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum in a 5% CO2 atmosphere at 37◦C (Kang et al., 2009).
The primary mouse macrophages were isolated from TLR2-
deﬁcient (TLR2−/−; JAX® Mice) and WT mice. The mice were
injected intraperitoneally (i.p.) with 4% thioglycolate, and peri-
toneal exudate cells were harvested 4 days later (van Lint et al.,
2010). More than 90% of the exudate cells were identiﬁed as
macrophages by microscopic analysis and non-speciﬁc esterase
staining (Sodhi et al., 2005). The macrophages were plated at a
density of 106 cells per well in 12-well plates.
Cloning, Expression, Purification and
Endotoxin Removal of HP0459 Protein
The HP0459 protein, which was reported as a secreted pro-
tein in a previous study, was encoded by SSUSC84_0459
(Liu et al., 2009). The HP0459 protein was cloned and puri-
ﬁed according to published methods (Liu et al., 2012). Brieﬂy,
the hp0459 gene was ampliﬁed from the chromosomal DNA
of SC-19 by PCR using the primers listed in Table 1. The
puriﬁed PCR product was inserted into pET-28a and har-
bored in E. coli BL21 (DE3) cells. HP0459 was induced with
0.5 mM isopropyl-b-D-thiogalactopyranoside (IPTG) and puri-
ﬁed by ultrasonication and Ni-NTA agarose chromatography.
The endotoxin in the puriﬁed recombinant protein was removed
using an Endotoxin Removal Kit (Genmed Scientiﬁcs Inc.
USA), and the endotoxin level was tested using a Quantitative
Chromogenic Tachypleus Amebocyte Lysate For Endotoxin
Detection kit (Chinese Horseshoe Crab Reagent Manufactory
Co., Ltd., Xiamen, China; Liu et al., 2011). The protein was then
treated using a 0.22-μm ﬁlter. After the above-mentioned treat-
ment, the HP0459 protein was stored at −80◦C.
RNA Extraction and qPCR Assay
After the treatment of RAW 264.7 cells with HP0459 at 10 μg
ml−1 for 10 h, the total RNA of the cells was extracted with
the TRIzol® reagent (Invitrogen, Paisley, UK), according to the
manufacturer’s guidelines. The RNA pellets were suspended in
RNase-Free water, and the DNA contamination of the RNA
was removed by DNase treatment (Promega, Madison, WI,
USA). cDNA was obtained from 4 μg of RNA by reverse tran-
scription using AMV reverse transcriptase (TAKARA, Japan)
and the oligo-dT primer (300 pmol) in a total reaction vol-
ume of 40 μl (Moore et al., 2005). Relative quantitative PCR
(qPCR) was performed to measure the mRNA levels of pro-
inﬂammatory cytokines (IL-1β, MCP-1 and TNF-α) using a
SYBR green PCR Kit (Roche) and the ABI ViiA7 instrument.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used
as the reference gene, and all of the primers used in the
TABLE 1 | Oligonucleotide primers used in this study.
Primers Primers sequence (5′–3′)a Functions
hp0459-F CCCGAATTCACGGAGGTAGCTAACGAAC For amplification of the hp0459 ORF gene
hp0459-R CCCCTCGAGTTATTCGGGTGTTGTAAATAG
hp0459-L1 AATGAATTCTTCCTGATAAGAAGGTGGCTAAC Upstream border of hp0459
hp0459-L2 AACGTCGACCCTGAAGGATCCTAATGAAGTTT
hp0459-R1 TTAGTCGACGCAATGTAATAACTCGAACTAG Downstream border of hp0459
hp0459-R2 CTCAAGCTTGACTAAACCATTAAGCCA
chp0459-1 CGCGCATGCCCTTTATTATGTCAAGTTCAGAT To complement hp0459 in the PCR assays
chp0459-2 CGCGAATTC TTATTCGGGTGTTGTAAATAG
MCP1-F TGGGTCCAGACATACATTA For qPCR assay
MCP1-R TCAGATTTACGGGTCAACT
TNFα-F CGATGAGGTCAATCTGCCCA For qPCR assay
TNFα-R CCAGGTCACTGTCCCAGCATC
IL1β-F CACCTGGTACATCAGCACCTCAC For qPCR assay
IL1β-R CATCAGAAACAGTCCAGCCCATAC
GAPDH-F CGTCGGTGCTGAGTATGTCGT For qPCR assay
GAPDH-R CAGTCTTCTGGGTGGCAGTGAT
P1 TAGTTTCTGATAAACTTCATTAGGA To identify the hp0459 gene by PCR
P2 AAATGCGCTCGAAATGA
P3 TGGAAATGTTCAAGTCAACC To identify the gdh gene by PCR
P4 CGTTTTTCTTTGATGTCCAC
P5 GCACAGATGCGTAAGGAG To identify the pSET4s by PCR
P6 ACTCTGTAGCACCGCCTA
aThe underlined nucleotides denote enzyme restriction sites.
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FIGURE 1 | Purification of the recombinant Hp0459 protein.
(A) SDS-PAGE. (B) Western blot analysis. The blot was probed with his tag
monoclonal antibody (Cali-Bio).
qPCR assay are listed in Table 1. The data were analyzed
using the ViiA7 software (Applied Biosystems; Zhao et al.,
2014).
Enzyme-Linked Immunosorbent Assay for
Cytokines
After treatment of RAW 264.7 cells with HP0459 at 10 μg ml−1
for 10 h, the protein levels of IL-1β, MCP-1 and TNF-α in the
cell culture supernatants were determined using commercially
available ELISA kits (Biolegend) according to the manufacturer’s
instructions.
Generation of an Isogenic hp0459 Deletion
Mutant and Complemented Strains
The construction of the hp0459-knockout mutant was per-
formed using a previously described procedure (Takamatsu et al.,
2001). Brieﬂy, DNA fragments were ampliﬁed from the
genomic DNA of SC-19 by PCR using two pairs of speciﬁc
primers, namely hp0459-L1/hp0459-L2 and hp0459-R1/hp0459-
R2 (Table 1), which carry EcoRI/SalI and SalI/HindI restriction
enzyme sites, respectively. The fragments were digested with the
corresponding restriction enzymes and sequentially ligated into
the temperature-sensitive S. suis–E. coli shuttle vector pSET4s
to generate the hp0459-knockout vector pSET4shp0459. To
obtain the isogenic mutant hp0459, competent cells of SC-19
FIGURE 2 | Induction of cytokine mRNA and protein in RAW 264.7
macrophages by recombinant HP0459 stimulation. RAW 264.7
macrophages were incubated with 10 μg ml−1 HP0459 and 200 ng ml−1 LPS
(positive control) for 10 h, as well as single culture media (negative control),
(A) the cytokine mRNA levels were then determined by qPCR, (B) and the
protein levels of IL-1β, MCP-1 and TNF-α in the culture supernatants were
determined by ELISA. The bars represent the standard errors of the means,
based on three independent experiments. **P < 0.01.
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FIGURE 3 | Construction and confirmation of hp0459 and the
complementary strain Chp0459. (A) Confirmation of the hp0459 mutant
by PCR using the primers pairs P1/P2 (to identify hp0459), P3/P4 (to identify
gdh), and P5/P6 (to identify the pSET4s). (B) Growth curves of the SC-19,
hp0459 and Chp0459 strains. The bacteria were cultured in TSB
containing 5% newborn bovine serum at 37◦C. The absorbance at 600 nm
was measured at intervals of 1 h. Results shown are representative of three
independent experiments. (C) Light microscope morphology of the SC-19,
hp0459 and Chp0459 strains using Gram staining. The bar indicates the
magnification size.
were subjected to electrotransformation with pSET4shp0459
as described previously (Takamatsu et al., 2001). The suspected
mutant was veriﬁed by PCR using three pairs of primers: P1/P2
(to identify hp0459), P3/P4 (to identify gdh) and P5/P6 (to iden-
tify the pSET4s).
The complemented strain of hp0459 was constructed as
described previously (Zhang et al., 2012). Brieﬂy, a DNA frag-
ment that contained the hp0459 gene and its predicted
upstream promoter was ampliﬁed by PCR using the primers
chp0459-1/chp0459-2 (Table 1), which carry SphI/EcoRI restric-
tion enzyme sites, respectively. To generate the recombinant
plasmid pSET2Chp0459, the fragment was digested with the
appropriate restriction enzymes and was cloned into the E. coli–
S. suis shuttle vector pSET2 carrying the same cohesive terminus.
The plasmid was then electrotransformed intohp0459 to obtain
the complemented Chp0459 strain.
Experimental Infections In Vitro and In Vivo
In vitro, RAW 264.7 cells were infected with 5 × 106 CFU of the
WT (SC-19), hp0459 or Chp0459 strains in the logarithmic
phase of growth. The supernatants were collected for western blot
analysis after 10 h at 37◦C.
All of the animal studies were performed according to the
experimental protocols approved by the Laboratory Animal
Monitoring Committee of Hubei Province, China. A total of 125
6-weeks-old female C57BL/6 mice were randomly divided into
three groups with 40mice per group, and the remaining ﬁve mice
were used as controls. The three groups of mice were challenged
intraperitoneally (i.p.) with 5 × 108 CFU log-phase WT (SC-19),
hp0459 or Chp0459 strains, respectively. At certain times post
infection (3, 6, 9, and 12 h), an equal number of mice in each
group were killed. Bacteriological isolation from the blood or part
of the spleen was performed essentially as described previously
(Zhang et al., 2011), and the lungs or another part of the spleen
were used to determine the IL-1β and TNF-α levels by qPCR.
Investigating the Recognition Receptor of
HP0459
Antibody blocking assays were performed to investigate the
recognition receptor of HP0459 in RAW264.7 cells using the
anti-TLR2 (eBioscience) and anti-TLR4 (BioLegend) antibodies.
Brieﬂy, RAW264.7 cells were pretreated using 8 μg of anti-TLR2
and anti-TLR4 antibody for 30 min respectively and then incu-
bated with 10 μg ml−1 HP0459 for 10 h. The expression levels of
various cytokines were determined by ELISA. According to the
conditions of cytokine activation, the recognition receptor of the
HP0459 was analyzed. In addition, TLR2−/−macrophages were
isolated from TLR2−/−mice to verify the results of the blocking
assays.
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FIGURE 4 | Induction of IL-1β and TNF-α by SS2 strains in RAW 264.7
macrophages. RAW 264.7 macrophages were incubated with the SC-19,
hp0459 and Chp0459 strains for 10 h. The levels of IL-1β and TNF-α in
the supernatants were measured by ELISA. The bars represent the SEs of the
means, based on three independent experiments. *P < 0.05.
Analysis of HP0459-Induced Cell Signal
Transduction Pathways
RAW264.7 macrophages (1 × 106 cells ml−1) were seeded into
12-well tissue culture plates. The cells were pretreated with the
following speciﬁc inhibitors for 30 min prior to the addition of
HP0459 (Liu et al., 2008): U0126 (for ERK1/2; 10 μM), SP600125
(for JNK; 10 μM), pyrrolidine dithiocarbamate (PDTC; for NF-
κB; 20 μM) and LY294002 (for PI3K; 20 μM). All inhibitors were
purchased from Cayman Chemical. Culture supernatants were
collected at the indicated times and stored at−80◦Cuntil assayed.
SDS-PAGE and Western Blot Analysis
To conﬁrm the HP0459-induced phosphorylation of signal trans-
duction molecules, a western blot analysis was performed. To
extract the cytosolic protein, after stimulation with HP0459
(10 μg ml−1) for 10 h, RAW264.7 cells were washed with cold
PBS and harvested by centrifugation. The pellets were then sus-
pended in RIPA lysis buﬀer with phosphatase inhibitor (Roche)
for 15 min on ice. The protein concentrations in the lysates were
quantiﬁed with the Bradford protein assay, and 40 μg of pro-
teins were subjected to 12% SDS-PAGE and transferred onto
a 0.22-μm nitrocellulose membrane. Subsequently, these pro-
teins were probed with speciﬁc Abs against the phosphorylated
forms of ERK1/2 and NF-κB p65 (Cell Signaling Technology,
FIGURE 5 | Bacteriological isolation from blood and spleen. C57BL/6
mice were challenged with 5 × 108 CFU of the log-phase SC-19, hp0459 or
Chp0459 strains. After infection for 3, 6, 9, and 12 h, bacteriological
isolation from the blood and spleens was performed. Results shown are
representative of three independent experiments.
Beverly, MA, USA), and β-actin was assessed as an internal
control using anti-β-actin antibody (Wuhan PMK Biotechnology
Co., Ltd.). The detection of the bands was performed using
HRP-conjugated secondary antibody and an enhanced chemi-
luminescence (ECL) system (Amersham Life Science, Arlington
Heights, IL, USA).
Statistical Analysis
The statistical signiﬁcance of the data was determined using
Student’s t test with GraphPad Prism software (San Diego, CA,
USA), and all the assays were repeated at least three times. For
all tests, a value of P < 0.05 was considered as the threshold for
signiﬁcance.
Results
Cytokine Secretion from RAW264.7 Cells
Stimulated with HP0459
After puriﬁcation by Ni-NTA agarose chromatography, the SDS-
PAGE (Figure 1A) and western blot analysis (Figure 1B) of
HP0459 revealed that the HP0459 protein was successfully puri-
ﬁed. The average endotoxin level in HP0459was∼0.05 endotoxin
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FIGURE 6 | Induction of IL-1β and TNF-αmRNA in vivo by stimulation with SS2 strains. C57BL/6 mice were challenged with 5 × 108 CFU of the log-phase
SC-19, hp0459 or Chp0459 strains. After infection for 3, 6, 9, and 12 h, the mRNA levels of IL-1β and TNF-α in the lungs and spleens were measured by qPCR.
Results shown are representative of three independent experiments.
units per milliliter via endotoxin removal. After the above-
mentioned treatment, to determine the pro-inﬂammatory role of
HP0459, RAW264.7 cells were stimulated with HP0459 at a con-
centration of 10 μg ml−1 for 10 h and analyzed by qPCR and
ELISA respectively. As shown in Figure 2, it was conﬁrmed that
HP0459 stimulation signiﬁcantly increased the expression levels
of IL-1β, MCP-1, and TNF-α (P < 0.01) by qPCR (Figure 2A)
and ELISA (Figure 2B) analyses.
Construction and Characterization of the
Mutant Strain hp0459
To study the role of HP0459 in the S. suis-induced pro-
inﬂammatory response, the HP0459-knockout mutant hp0459
was constructed by homologous recombination, and the double-
crossover event was conﬁrmed by PCR (Figure 3A). To examine
the growth characteristics of the mutants in vitro, the OD600 val-
ues of cultures of the SC-19, hp0459 and Chp0459 strains in
TSB containing 10% newborn bovine serum at 37◦C were deter-
mined (Figure 3B), and Gram-staining of these three strains was
also performed (Figure 3C). No signiﬁcant diﬀerence in growth
was found between the SC-19, hp0459 and Chp0459 strains.
Pro-inflammatory Attenuation Induced by
the hp0459 Strain In Vitro and In Vivo
After construction of the hp0459 strain, the role of HP0459 in
the S. suis-induced pro-inﬂammatory response was assessed in
RAW264.7 cells in vitro. The culture supernatants of RAW264.7
cells incubated with the SC-19, hp0459 and Chp0459 strains
were harvested, and the levels of IL-1β and TNF-α in these super-
natants were measured by ELISA. The results showed that the
pro-inﬂammatory activity of thehp0459 strain was signiﬁcantly
lower than those of the SC-19 and Chp0459 strains (Figure 4).
This ﬁnding suggested that HP0459 plays an important role in
the S. suis-induced pro-inﬂammatory response in vitro.
The role of HP0459 in vivo in the S. suis-induced pro-
inﬂammatory response was then assessed using an experimental
infection model in C57BL/6 mice. Bacteriological isolation from
the blood and part of the spleen showed that, compared with
the SC-19 and Chp0459 strains, the bacterial content of the
hp0459 strain was signiﬁcantly increased (Figure 5). At the
same time, the lungs and another part of the spleen from infected
and control mice were separated to extract the total RNA, and
the mRNA levels of IL-1β and TNF-α were measured by qPCR.
The results indicated that the mRNA levels of IL-1β and TNF-
α induced by the hp0459 strain in vivo were signiﬁcantly
lower than those induced by the SC-19 and Chp0459 strains
(Figure 6). Thus, the HP0459 protein plays an important role in
the S. suis-induced pro-inﬂammatory response.
HP0459 Protein Induced the Expression of
IL-1β, MCP-1 and TNF-α by TLR2
To determine the recognition receptor responsible for the
HP0459-mediated induction of cytokines, antibody blocking
assays were performed. Compared with the positive control,
anti-TLR2 antibody could signiﬁcantly reduce the expression of
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FIGURE 7 | Recognition receptor of the HP0459-stimulated pro-infla-
mmatory response. (A) Antibody blocking assays. After pretreatment with
8 μg of anti-TLR2 and anti-TLR4 antibody for 30 min, RAW 264.7
macrophages were incubated with 10 μg ml−1 HP0459 for 10 h. The
expression levels of various cytokines were then determined by ELISA.
(B) Primary peritoneal macrophages were isolated from TLR2−/− and WT
mice and incubated with 10 μg ml−1 HP0459 for 10 h. The induction of IL-1β,
MCP-1 and TNF-α in the supernatants was then determined by ELISA. The
bars represent the SEs of the means, based on three independent
experiments. *P < 0.05, **P < 0.01.
IL-1β, MCP-1 and TNF-α induced by HP0459, whereas anti-
TLR4 antibody could not (Figure 7A). The results showed that
the HP0459-induced cytokine secretion may depend on TLR2.
To verify this result, TLR2−/− and WT macrophages were
isolated from TLR2−/− and WT mice, respectively, and were
incubated with HP0459. The results show that HP0459 could
signiﬁcantly induce cytokine secretion in WT macrophages but
not in TLR2−/− cells (Figure 7B), demonstrating that the
HP0459 protein can induce a TLR2-dependent pro-inﬂammatory
response.
HP0459-Induced Cell Signal Transduction
Pathways in RAW264.7 Cells
Next, to further elucidate the mechanisms through which the
HP0459 protein induced cytokine secretion, we investigated
the cell signal transduction pathways in HP0459-stimulated
RAW264.7 cells. RAW264.7 cells were pretreated with speciﬁc
inhibitors of several cell signal pathways for 30 min and were
then were incubated with HP0459 for 10 h. The levels of IL-
1β, MCP-1, and TNF-α in the supernatants were quantiﬁed by
ELISA. As shown in Figure 8A, the ERK 1/2 MAPK inhibitor
(U0126) signiﬁcantly decreased the HP0459-induced cytokine
production, and the NF-κB inhibitor (PDTC) induced a lower
degree of reduction. This result suggested that the HP0459-
induced cytokine production likely primarily depends on the
phosphorylation of ERK 1/2 MAPK. To verify this hypothesis,
we performed a western blotting analysis to measure the phos-
phorylation of ERK 1/2 MAPK and NF-κB in RAW264.7 cells
induced by HP0459 stimulation (Figure 8B). The results showed
that the phosphorylation of ERK 1/2 MAPK was signiﬁcantly
enhanced, whereas the phosphorylation of NF-κB was slight. In
addition, a western blot analysis with anti-actin antibody was
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FIGURE 8 | Signal transduction pathways of the HP0459-stimulated
pro-inflammatory response in RAW 264.7 macrophages. (A) Effect of ERK
1/2 (U0126), JNK (SP600125), PI3K (LY294002) and NF-κB (PDTC) inhibitors on
cytokine production during HP0459 stimulation. After incubation with the
inhibitors for 30 min, RAW 264.7 macrophages were stimulated with 10 μg
ml−1 HP0459 for 10 h. The cytokine levels were then determined by ELISA.
Data are expressed as the mean ± SD of three independent experiments.
(B) HP0459-induced phosphorylation of ERK 1/2 MAPK in RAW264.7
macrophages. RAW264.7 macrophages were stimulated with HP0459 (10 μg
ml−1) for 10 h. The cell lysates were analyzed by western blotting using specific
antibodies against ERK 1/2 MAPK, phospho-ERK 1/2 MAPK, NF-κB and
phospho-NF-κB. At the same time, β-actin was assessed as an internal control
using anti-β-actin antibody. Results shown are representative of three
independent experiments. *P < 0.05, **P < 0.01.
used to conﬁrm that equivalent amounts of the samples were
loaded into the gels. These results suggested that signal trans-
duction pathway ERK 1/2 MAPK play a primary role in the
pro-inﬂammatory response induced by HP0459 stimulation in
RAW264.7 cells.
Discussion
Due to the high prevalence of S. suis-induced diseases in humans
in Southeast and East Asia, pathogen has been increasingly inves-
tigated (Fittipaldi et al., 2012). Although the pathogenesis of S.
suis infection is not entirely known at present, several viewpoints
have been generally recognized, and one of these is that inﬂam-
mation plays an important role in S. suis infection (Segura et al.,
2006). After pathogen invasion into a host, the innate immune
system of the host will recognize key molecular signatures borne
by PAMPs to activate the inﬂammatory response in order to
clear pathogens (Martinon and Tschopp, 2005). However, dur-
ing S. suis infection, the inﬂammatory response is excessively
activated and thus plays an important role in most clinical signs
of S. suis disease, including meningitis, septicemia and sudden
death (Dominguez-Punaro Mde et al., 2008). Thus, it is signif-
icant to identify the pro-inﬂammatory molecules of S. suis in
order to understand its pathogenesis. In this study, it was found
that HP0459 could signiﬁcantly activate inﬂammatory response
in RAW264.7 cells, but heat-killed HP0459 couldn’t (data not
shown). Further, we elucidated the mechanism of HP0459 induc-
ing inﬂammation. This result contributes to the understanding of
the excessive inﬂammation induced by S. suis.
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During S. suis infection, this pathogen can be recognized by
some receptors, including CD14, TLR2, TLR6, and TLR9. CD14
has been considered one of the recognition receptors of LPS,
the major component of the outer membrane of Gram-negative
bacteria (Wright et al., 1990), and CD14 has been shown to be
important in the recognition of cell wall constituents of Gram-
positive bacteria (Wright, 1995; Moreillon and Majcherczyk,
2003). A previous study proved that S. suis can mediate CD14-
dependent cytokine and chemokine production by humanmono-
cytes (Segura et al., 2002). Because CD14 lacks transmembrane
and intracellular domains, it is not able to transduce the signal
by itself. Thus, to activate the CD14-dependent inﬂammatory
response, additional transmembrane receptors, such as TLR2,
are required (Manukyan et al., 2005). TLR2, as a major pat-
tern recognition receptor for ligands derived from Gram-positive
bacteria (Kawai and Akira, 2005), has been shown to play an
important role during S. suis ST1 strain interactions with mouse,
swine and human cells (Graveline et al., 2007; Zheng et al., 2011,
2012). In addition, it has been indicated that not only TLR2
but also TLR6 and TLR9 play an important role on cell acti-
vation through in vitro studies carried out with the whole cells
of the epidemic ST7 strain and human peripheral blood cells
(Zheng et al., 2012). In the present study, using antibody block-
ing and TLR2−/− mouse macrophages assays, we found that
TLR2 plays an important role in the inﬂammatory response
activated by HP0459. This is consistent with S. suis-induced
pro-inﬂammatory response, which is primary TLR2-dependent.
However, LipoP prediction of HP0459 displayed that the signal
peptide of HP0459 belonged to SpI (lipoprotein signal peptide
belonged to SpII; Hutchings et al., 2009). This result suggested
that the recognition of HP0459 may be diﬀerent from bacte-
rial lipoproteins. So, the mechanisms of HP0459 recognized by
TLR2 need further research. We have proved that HP0459 con-
tributes to pro-inﬂammatory response during S. suis infection.
And it is known that there is a close link between excessive
inﬂammation and the development of Streptococcus toxic shock
syndrome (STSS; Zhao et al., 2011). This implies that HP0459
may be responsible for the pathogenesis of STSS caused by
S. suis 2.
Compared with the SC-19 strains, the pro-inﬂammatory acti-
vation of the hp0459 strain in vivo was found to be signiﬁcantly
reduced in the present study. However, the mouse experiment
showed that the lethality of the SC-19 and hp0459 strains were
not signiﬁcant diﬀerent after challenge with the same CFUs (data
not shown). To explain this result, we performed bacteriological
isolation from the blood and spleen, and compared with the SC-
19 and Chp0459 strains, the bacteria content of the hp0459
strain was signiﬁcantly increased (Figure 5). It is known that
higher bacterial counts of pathogenic bacteria in vivo may be
an important cause leading to disease worsening (Sullivan et al.,
1982). Thus, this ﬁnding suggests that inﬂammation is mainly but
not exclusively responsible for the pathology of S. suis and that the
bacteria content also plays an important role.
Finally, our data identiﬁed a novel pro-inﬂammatory protein
denoted HP0459 from S. suis. Further, we demonstrated that
HP0459 induces a TLR2-dependent pro-inﬂammatory response
in RAW 264.7 macrophages via activation of the ERK1/2
pathway. These ﬁndings could be important for improving our
understanding of the excessive inﬂammation induced by S. suis
and may aid the development of therapies against SS2 infection.
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